ALT
vs
S
S&P/ASX 300
ALT
Over the past 12 months, ALT has underperformed S&P/ASX 300, delivering a return of 0% compared to S&P/ASX 300's +2% growth.
Stocks Performance
ALT vs S&P/ASX 300
Performance Gap
ALT vs S&P/ASX 300
Performance By Year
ALT vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Analytica Ltd
Glance View
Analytica Ltd. engages in the design development, and supply of class 1 and class 2 medical devices. The company is headquartered in Brisbane, Queensland. The company went IPO on 2000-10-25. Analytica’s lead product is the PeriCoach system is an e-health treatment system for women who suffer stress urinary incontinence. PeriCoach includes a device, Web portal, and smartphone app and the device evaluates activity in pelvic floor muscles. This information is transmitted to a smartphone app and can be loaded to PeriCloud where physicians can monitor patient progress via the Web portal. The company is also commercializing the AutoStart Burette infusion system. The AutoStart burette set automatically restarts the delivery of intravenous fluid once the burette has dispensed its predetermined amount of liquid or drug. Automatic restart of the IV fluid, once the drug is dispensed can provide enormous savings in nursing time during and following a medication event and reduces the risk of blood clots forming that may obstruct the intravenous cannula.
